Zobrazeno 1 - 7
of 7
pro vyhledávání: '"E. Bodil Roth"'
Autor:
Elke Theander, E. Bodil Roth, Anna-Maria Larsson, Pål Stenberg, Klas Sjöberg, M. Sandberg-Wollheim, E. Londos
Publikováno v:
Scandinavian Journal of Immunology. 67:626-631
Coeliac disease (CD) is becoming a model for understanding the pathogenesis of autoimmune disorders. In CD, antibodies against transglutaminase 2 (TG2) and specific residues of gliadins have been identified. A similar situation is seen in rheumatoid
Publikováno v:
European Journal of Internal Medicine. 19:83-91
In 1997, a German group demonstrated that the antigen of the biomarker EMA (endomysial antibodies) in coeliac disease is a calcium-dependent thiol enzyme, transglutaminase type 2 (TG2). This most important discovery opened up an exciting field of res
Publikováno v:
Journal of Pharmacy and Pharmacology. 56:1389-1398
Desmopressin is a synthetic vasopressin analogue mainly used in treatment of diabetes insipidus and nocturia. Studies in rats have revealed a sex difference in the response to a vasopressin infusion, which was diminished after treatment with an NSAID
Publikováno v:
Autoimmunity. 36:221-226
Tissue transglutaminase (tTg) has been identified as the major autoantigen in coeliac disease (CD). ELISA methods have been developed for measuring the autoantibody. There are divergent reports on the effects of calcium on the antibody binding to tTg
Publikováno v:
Autoimmunity. 35(5)
Tissue transglutaminase (tTg) has been identified as an autoantigen in coeliac disease (CD). There is a marked homology between different forms of transglutaminase, such as tTg and coagulation factor XIII. We compared titres of both IgA- and IgG-anti
Publikováno v:
Journal of Pharmacy & Pharmacology; Nov2004, Vol. 56 Issue 11, p1389-1398, 10p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.